Nous vous informons que ce site est conforme à la législation française actuelle sur les dispositifs médicaux.
ESTRO was founded in 1980, the European SocieTy for Radiotherapy & Oncology, is a non-profit and scientific organisation that fosters the role of Radiation Oncology in order to improve patients' care in the multimodality treatment of cancer.
The purpose of ESTRO is to promote radiotherapy in all its aspects by setting standards in education and practice, facilitating research, stimulating exchange of scientific knowledge and promoting collaboration in radiotherapy in Europe and beyond as well as with other professions involved in cancer treatment. The society has today over 5000 multi-professional members focusing on radiation oncology. This year the congress will take place in Vienna, Austria from November 28th to December 1st.
Due to the actual COVID-19 crisis and for health and safety reasons, ESTRO is going to adopt a new concept: a reduced Congress with a live programme in Vienna along with a digital participation. They will communicate more details in the coming weeks.
The theme of ESTRO 2020 is “Translating research and partnership into optimal health”. The innovation in radiation therapy evolve rapidly. The difficulty is to translate into clinical application this results to provide optimal benefit to patient.
JOIN US AT THE 2020 ESTRO ANNUAL MEETING!
Nanobiotix will share an update on the results of the clinical trial in liver and head and neck.
This year, we are proud to have one poster on liver study presented by Pr. De Baère and and an oral presentation presented by Pr. Le Tourneau. You can find more information about this by visiting the ESTRO website link below.
Session Type: Poster Highlights Session Title: Poster highlights 5 CL : GI Title: Phase I/II trial of NBTXR3 activated by SBRT in patients with HCC and liver metastases Session Presenter: Pr. Thierry De Baere Poster Viewing Time: TBD